Author:
Li Wenru,An Ni,Tian Yuan,Zhang Siqi,Guo Ling,Zhao Tongtong,Su Rongjian,Cai Dong
Reference23 articles.
1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008
2. Lenvatinib: A review in hepatocellular carcinoma;Al-Salama;Drugs,2019
3. Hepatocellular carcinoma: Etiology and current and future drugs;Jindal;J. Clin. Exp. Hepatol.,2019
4. Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics;Lathia;Cancer Chemother. Pharmacol.,2006
5. L. Gong, M.M. Giacomini, C. Giacomini, et al, PharmGKB summary: sorafenib pathways, Pharmacogenet. Genomics, 27 (1017) 240.